ARCHIVES

Cell Behavior Changes Noted At Baltimore Symposium

This article is from The Cancer Letter archive.

Vol. 08 No. 02 | January 8, 1982

Download PDF Visit The Full Archive

Related Articles

Contract Awards Sole Source Negotiations

January 13, 1978

In Brief: Richard Fisher Named Physician-in-Chief, Executive Vice President at Fox Chase Cancer Center

December 7, 2012

Clinical Trials Approved By NCI CTEP Last Month

July 29, 2011

Tasigna Shows High Response, PFS Benefit Compared to Gleevec in Phase III CML Study

December 26, 2014

NTP Board Approves Four New Concepts

October 8, 1982

Phase III Five-Year Data Show Erbitux Increases Survival Of Head And Neck Cancer

September 26, 2008